PWE-158 Thymosin Beta 4 as a Putative Marker in Neuroendocrine Tumours

Gut - United Kingdom
doi 10.1136/gutjnl-2013-304907.446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Thymosin Beta 4: A Ubiquitous Peptide in Rat and Mouse Tissues.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

PWE-126 Survival and Recurrent Disease in Patients With Resected Primary Small Bowel Neuroendocrine Tumours

Gut
Gastroenterology
2012English

Thymosin Beta-4 a/T Polymorphism and Acute Coronary Syndrome Risk

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
2019English

Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver

PLoS ONE
Multidisciplinary
2015English

Neglected Conditions: Neuroendocrine Tumours

CMAJ
Medicine
2014English

Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas Aeruginosa-Induced Keratitis

Cells
2018English

Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells

PLoS ONE
Multidisciplinary
2016English

Thymosin Beta 4 Induces Hair Growth via Stem Cell Migration and Differentiation

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2007English

Molecular Imaging for Neuroendocrine Tumours

Swiss Medical Weekly
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy